Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAmigo Resources Regulatory News (AMGO)

Share Price Information for Amigo Resources (AMGO)

Share Price is delayed by 15 minutes
Get Live Data
2.375    0.00 (0.00%)
Bid:
2.25
Ask:
2.50
Spread: 0.25 (11.111%)
Market Cap: £28.26m
AMGO Live PriceLast checked at - London Stock Exchange

Intraday Amigo Resources Share Chart

Form 8.3 - Replacement

12 Feb 2020 17:15

RNS Number : 8271C
Amigo Holdings PLC
12 February 2020
 

FORM 8.3

FORM 8.3 REPLACEMENT

 

The Form 8.3 - Amigo Holdings PLC announcement released on 12.02.20 at 09.46 GMT under RNS No 7615C has been amended.

 

Amendments are identified with an asterisk (*).

 

The full amended text is shown below.

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

MIC Capital Partners (Public) Parallel Cayman, LP (Fund)

 

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

MIC Capital Partners (Public) (US) IM, LLC (Fund Manager)

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Amigo Holdings plc

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

N/A

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

10 February 2020

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

No

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

0.25p ordinary shares

 

 

Interests

Short positions

 

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

28,089,706 *

5.91

0

0

(2) Cash-settled derivatives:

 

0

0

0

0

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

0

0

0

0

 

TOTAL:

28,089,706

5.91

0

0

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other employee options)

 

Class of relevant security in relation to which subscription right exists:

N/A

Details, including nature of the rights concerned and relevant percentages:

N/A

 

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

0.25p ordinary shares

Purchase

 

409,649

£0.55

 

 

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

 

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

 

 

 

 

 

 

 

 

 

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

 

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

 

 

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

None

 

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

None

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

No

 

 

Date of disclosure:

12 February 2020

Contact name:

Thomas Donegan, Shearman & Sterling LLP

Telephone number*:

+44 207 655 5566

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel's Market Surveillance Unit.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
RETTTMRTMTBBBIM
Date   Source Headline
29th Jan 20206:38 pmRNSForm 8.3 - Amigo Holdings plc
29th Jan 20201:07 pmBUSForm 8.3 - AMIGO HOLDINGS PLC
29th Jan 202010:05 amRNSForm 8.5 (EPT/RI)- Amigo Holdings plc
29th Jan 20208:17 amRNSForm 8.5 (EPT/RI) Amigo Holdings Plc
28th Jan 202012:50 pmBUSForm 8.3 - AMIGO HOLDINGS PLC
28th Jan 202011:18 amRNSForm 8.3 - Amigo Holdings plc
28th Jan 202010:32 amRNSForm 8.5 (EPT/RI)- Amigo Holdings plc
28th Jan 20208:55 amRNSForm 8.5 (EPT/RI) Amigo Holdings Plc
27th Jan 20204:53 pmPRNForm 8.3 - Amigo Holdings
27th Jan 20207:00 amRNSStrategic Review and Statement from Richmond Group
13th Jan 20202:02 pmRNSHolding(s) in Company
10th Jan 20205:20 pmRNSHolding(s) in Company
10th Jan 20205:18 pmRNSHolding(s) in Company
10th Jan 20204:00 pmRNSDirector and PDMR Dealing
7th Jan 20203:54 pmRNSHolding(s) in Company
13th Dec 20198:00 amRNSCommittee Changes
11th Dec 20196:29 pmRNSDirector/PDMR Dealing
9th Dec 20197:00 amRNSBoard Changes
5th Dec 20197:00 amRNSFree Float
2nd Dec 20197:00 amRNSHolding(s) in Company
2nd Dec 20197:00 amRNSDirector/PDMR Shareholding
29th Nov 20198:14 amRNSRichmond Group Board Representation
28th Nov 20197:02 amRNSHalf-year Report
28th Nov 20197:00 amRNSClarification on Regulatory Update
27th Nov 20191:57 pmRNSRegulatory Update
22nd Nov 20197:00 amRNSRichmond Group Board Representation
21st Nov 201911:15 amRNSHolding(s) in Company
13th Nov 20193:17 pmRNSHolding(s) in Company
8th Nov 20195:15 pmRNSDirector/PDMR Shareholding
29th Oct 20193:45 pmRNSHolding(s) in Company
10th Oct 20195:30 pmRNSDirector and PDMR dealing
10th Oct 20197:00 amRNSNotice of Results
4th Oct 20196:04 pmRNSFree Float
23rd Sep 20195:06 pmRNSDirector/PDMR Shareholding
23rd Sep 201911:45 amRNSDirector/PDMR Shareholding
12th Sep 201910:56 amRNSDirector/PDMR Shareholding
6th Sep 20194:41 pmRNSSecond Price Monitoring Extn
6th Sep 20194:35 pmRNSPrice Monitoring Extension
4th Sep 20197:00 amRNSHolding(s) in Company
2nd Sep 20194:35 pmRNSPrice Monitoring Extension
2nd Sep 20198:00 amRNSDirector/PDMR Shareholding
30th Aug 201911:48 amRNSHolding(s) in Company
29th Aug 20197:00 amRNS1st Quarter Results
28th Aug 20194:40 pmRNSSecond Price Monitoring Extn
28th Aug 20194:35 pmRNSPrice Monitoring Extension
22nd Aug 201912:07 pmRNSSecond Price Monitoring Extn
22nd Aug 201912:02 pmRNSPrice Monitoring Extension
16th Aug 201912:08 pmRNSSecond Price Monitoring Extn
16th Aug 201912:02 pmRNSPrice Monitoring Extension
14th Aug 201912:07 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.